Compare Stock Earnings
Side-by-side earnings, revenue, and financial performance comparison
GSK Plc
$56.39
-0.53%
Mkt Cap: $72.8B
Avg ER Move: ±2.8%
Next Earnings
Apr 29, 2026 BMO
In 22 days
Consensus EPS
$1.20
Whisper EPS
$1.30
Revenue Whisper
$8.29B
Earnings Track Record (7Q)
7 Beats
0 Misses
Whisper Beat: 100%
Last 4 Quarters
Q1'26
$0.70
✅ BEAT +9.3%
📈 +3.4%
$8.62B
Q4'25
$1.46
✅ BEAT +24.5%
📈 +2.2%
$8.55B
Q3'25
$1.24
✅ BEAT +11.7%
📉 -4.7%
$7.99B
Q2'25
$1.20
✅ BEAT +15.4%
📉 -2.8%
$7.52B
Latest Revenue
$8.62B
+6.2% YoY
Gross: 69.7%
Op: 12.8%
Net: 7.4%
Lilly(Eli) & Company
$926.98
-0.92%
Mkt Cap: $754.3B
Avg ER Move: ±2.7%
Next Earnings
Apr 30, 2026 BMO
In 23 days
Consensus EPS
$7.50
Whisper EPS
$7.91
Revenue Whisper
$18.15B
Earnings Track Record (7Q)
5 Beats
2 Misses
Whisper Beat: 57%
Last 4 Quarters
Q1'26
$7.54
✅ BEAT +5.2%
📈 +2.3%
$19.29B
Q4'25
$7.02
✅ BEAT +10.2%
📈 +2.2%
$17.60B
Q3'25
$6.31
✅ BEAT +12.9%
📉 -2.4%
$15.56B
Q2'25
$3.34
❌ MISS -5.6%
📈 +3.7%
$12.73B
Latest Revenue
$19.29B
+42.6% YoY
Gross: 85.1%
Op: 45.5%
Net: 34.4%
Johnson & Johnson
$240.92
-0.87%
Mkt Cap: $586.0B
Avg ER Move: ±0.5%
Next Earnings
Apr 14, 2026 BMO
In 7 days
Consensus EPS
$2.69
Whisper EPS
$3.02
Revenue Whisper
$23.36B
Earnings Track Record (7Q)
6 Beats
0 Misses
Whisper Beat: 43%
Last 4 Quarters
Q1'26
$2.46
➖ MET +0%
📈 +0.2%
$24.56B
Q4'25
$2.80
✅ BEAT +1.4%
📈 +0.2%
$23.99B
Q3'25
$2.77
✅ BEAT +3.4%
📉 -1.1%
$23.74B
Q2'25
$4.54
✅ BEAT +100.9%
📈 +0.2%
$21.89B
Latest Revenue
$24.56B
+9.1% YoY
Gross: 86.4%
Op: 22.0%
Net: 20.8%
📊 Head-to-Head Comparison
| Metric | GSK | LLY | JNJ |
|---|---|---|---|
| Price | $56.39 | $926.98 | $240.92 |
| Market Cap | $72.8B | $754.3B | $586.0B |
| EPS Beat Rate | 100% | 71% | 86% |
| Whisper Beat Rate | 100% | 57% | 43% |
| Avg ER Move | ±2.8% | ±2.7% | ±0.5% |
| Next EPS Consensus | $1.20 | $7.50 | $2.69 |
| Next EPS Whisper | $1.30 | $7.91 | $3.02 |
| Revenue Whisper | $8.29B | $18.15B | $23.36B |
| Latest Revenue | $8.62B | $19.29B | $24.56B |
| Revenue Growth YoY | +6.2% | +42.6% | +9.1% |
| Gross Margin | 69.7% | 85.1% | 86.4% |
| Operating Margin | 12.8% | 45.5% | 22.0% |
| Net Margin | 7.4% | 34.4% | 20.8% |
| Earnings Date | Apr 29, 2026 | Apr 30, 2026 | Apr 14, 2026 |
📈 Visual Comparison
EPS Surprise % (Last 8 Quarters)
Revenue Trend
Post-Earnings Price Move
Margin Comparison
⚡ Quick Stats
GSK
100% beat rate
· ±2.8% avg move
LLY
71% beat rate
· ±2.7% avg move
JNJ
86% beat rate
· ±0.5% avg move